Prolia

Type: Product
Name: Prolia
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Fracture risk drug now for men

Denosumab, a monoclonal antibody that reduces bone resorption, is now licensed for the treatment of osteoporosis in men who are at increased risk of fractures. Under the brand name Prolia, denosumab was formerly restricted to women as a treatment for ... [Published Trends In Urology & Men's health - 6 hours ago]
First reported Aug 28 2014 - Updated Aug 29 2014 - 1 reports

Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen submits U.S. application to sell cholesterol-fighting drug

[Reuters] – Amgen Inc said it submitted an application to the U.S. Food and Drug Administration to market its cholesterol-lowering drug, evolocumab. The injectable drug works by blocking PCSK9, a naturally occurring …Read more on this.Amgen Inc. (AMGN) ... [Published Jutia Group - Aug 28 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Why Amgen Stock Is A Long-Term Investment Opportunity

Summary Amgen has a top-quality pipeline that should sustain long-term growth. Amgen's restructuring plan will provide savings and will enable the company to focus on growth areas. Amgen is generating strong cash flows and returns value to its shareholders ... [Published Seeking Alpha - Aug 27 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Pain after 6 years on different medication

First time posting and hopping for help. I have been diagnosed with osteoporosis 6 years ago during a x-Ray for pneumonia at the age of 42. I'm not sure of my scores because I haven't had a bone scan in a year in a half. I was showing some improvement ... [Published HealthBoards - Aug 19 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Prolia And Femur Fractures: Three Recent Case Reports Indicate A Possible Safety Issue For This Relatively New Drug From Amgen

While Prolia Is An Alternative To Bisphosphonates Such As Fosamax, It Has Similar Increased Risk Of Low-Stress Femur Fractures Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com ) The association between stress fractures of the femur, or ... [Published Drug Injury Watch - Aug 12 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

Amgen reports bumper results... then wields job axe new

Amgen is the world's biggest maker of biologic drugs– 31 July 2014Biologic drug-maker Amgen is to shed 12% to 15% of its worldwide workforce and close four sites, despite reporting stellar second-quarter results that trounced Wall Street expectations ... [Published Belfast Telegraph - Jul 31 2014]
First reported Jul 30 2014 - Updated Jul 31 2014 - 3 reports

Amgen Q2 sales rise, company to lay off up to 2,900

Share this article:Prolia sales soar 40%, to $264 million, compared to the same period last yearAmgen powered through its second quarter with sales rising to $4.9 billion, up 8% compared to the same period last year, when sales hit $4.6 billion.Much of ... [Published Medical Marketing And Media - Jul 31 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 5 reports

Amgen, Inc. (AMGN) Announces Revenue Growth And Profitability In The Second Quarter

Amgen, Inc. (NASDAQ : AMGN )   announced its second quarter financial results on July 29, 2014. Amgen’s total revenues increased by 11% on the year to $5.18 billion. Enbrel, Kyprolis, Prolia and XGEVA are the strongest performers among the Amgen, Inc. ... [Published InsiderMonkey.com - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Amgen to Lay off up to 2,900; 2Q Revenues up 11 Percent

Amgen reported that its total revenues increased 11 percent to $5,180 million, with 8 percent product sales growth driven by strong performance across the portfolio, particularly Enbrel (etanercept), Kyprolis (carfilzomib), Prolia (denosumab) and XGEVA ... [Published Pharmaceutical Manufacturing Magazine - Jul 30 2014]
Entities: Amgen Inc, Enbrel, Denosumab
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Dr. Keith Roach: Patient prefers to split thyroid meds

Dear Dr. Roach: I had my thyroid removed for a goiter 35 years ago. My doctor put me on 100 mcg of thyroid medication; however, when I took it, I got sick. My hands shook, and my heart beat very quickly (over 100). So one doctor told me to split it, and ... [Published Herald & Review - Jul 28 2014]
First reported Jul 23 2014 - Updated Jul 24 2014 - 2 reports

GlaxoSmithKline slashes forecast as 2nd-qtr sales and earnings fall sharply

UK pharma giant GlaxoSmithKline (LSE: GSK) saw its shares fall 3.9% to £45.94 shortly after the company reported disappointing second-quarter 2014 financial results, and chief executive Sir Andrew Witty admitted that "it is now unlikely that we will deliver ... [Published Pharma Letter - Jul 24 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

Human medicines European public assessment report (EPAR): Prolia, denosumab, Revision: 5, Authorised

Entities: Prolia, Denosumab, Humanism

Quotes

"One thing that can't be ignored is the tie to the commercialization of space and the integration of these industries," said Ferguson. "The biotech and pharmaceutical companies are using spaceflight as a medium to study their drugs and do the preclinical work that's really important for FDA approval."
"We present a case of bilateral low-energy femoral shaft fractures over a 1-year period in a woman after discontinuation of long-term alendronate therapy and initiation of treatment with denosumab.... "
"Kyprolis is an important building block in our robust, differentiated pipeline, [which] continues to show notable progress."
...have been very supportive, so it is with great reluctance that we acknowledge the need to exit," said Robert A Bradway, Amgen’s chairman and CEO. "At each site, we are actively engaging in discussions with third parties about potential future use of the facilities."

More Content

All (36) | News (33) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Fracture risk drug now for men [Published Trends In Urology & Men's health - 6 hours ago]
Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen... [Published Jutia Group - Aug 28 2014]
Why Amgen Stock Is A Long-Term Investment Oppor... [Published Seeking Alpha - Aug 27 2014]
Microgravity Research Breaks Down How to Build ... [Published MoneyShow.com - Aug 25 2014]
Market Update: Amgen Inc (NASDAQ:AMGN) – Lilly ... [Published Jutia Group - Aug 21 2014]
Pain after 6 years on different medication [Published HealthBoards - Aug 19 2014]
Osteoporosis drugs destroy bones they are 'alle... [Published Examiner.com - Aug 18 2014]
Prolia And Femur Fractures: Three Recent Case R... [Published Drug Injury Watch - Aug 12 2014]
Why Amgen Is Slimming Up [Published Seeking Alpha - Aug 05 2014]
Drug Approvals and Earnings Releases - Research... [Published SearchBug - Aug 04 2014]
Amgen to cut up to 3,000 jobs, most in U.S., cl... [Published Center Watch - Jul 31 2014]
Amgen reports bumper results... then wields job... [Published Belfast Telegraph - Jul 31 2014]
Amgen Q2 sales rise, company to lay off up to 2... [Published Medical Marketing And Media - Jul 31 2014]
Amgen - Continued Appeal With Shares Trading At... [Published Seeking Alpha - Jul 30 2014]
Amgen Price Target Raised by Various Analysts [Published Benzinga.com - Jul 30 2014]
Amgen, Inc. (AMGN) Announces Revenue Growth And... [Published InsiderMonkey.com - Jul 30 2014]
Amgen Pleases the Street -- but Will Layoffs Ke... [Published West Hartford News - Jul 30 2014]
Amgen Reports Stellar Earnings, Raises Guidance [Published Yahoo! Finance - Jul 30 2014]
Amgen’s 2nd-qtr beats expectations, but firm sl... [Published Pharma Letter - Jul 30 2014]
Amgen to wield axe on 2,900 jobs [Published Pharmafocus - Jul 30 2014]
Amgen to Lay off up to 2,900; 2Q Revenues up 11... [Published Pharmaceutical Manufacturing Magazine - Jul 30 2014]
Amgen (AMGN) CEO Bob Bradway on Q2 2014 Results... [Published Seeking Alpha - Jul 30 2014]
Biotech giant axes up to 2,900 jobs [Published BT.com - Jul 30 2014]
Biotech drugmaker Amgen laying off at least 2,400 [Published Kentucky.com - Jul 30 2014]
ACCURACY, FAST RESPONSE AND CONVENIENCE GOAL OF... [Published Panhandle Post - Jul 30 2014]
Will Amgen (AMGN) Disappoint This Earnings Season? [Published Zacks.com - Jul 28 2014]
Dr. Keith Roach: Patient prefers to split thyro... [Published Herald & Review - Jul 28 2014]
Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen A... [Published Jutia Group - Jul 25 2014]
GlaxoSmithKline slashes forecast as 2nd-qtr sal... [Published Pharma Letter - Jul 24 2014]
Half Yearly Report [Published TrustNet - Jul 23 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Pain after 6 years on different medication [Published HealthBoards - Aug 19 2014]
First time posting and hopping for help. I have been diagnosed with osteoporosis 6 years ago during a x-Ray for pneumonia at the age of 42. I'm not sure of my scores because I haven't had a bone scan in a year in a half. I was showing some improvement ...
Prolia And Femur Fractures: Three Recent Case R... [Published Drug Injury Watch - Aug 12 2014]
While Prolia Is An Alternative To Bisphosphonates Such As Fosamax, It Has Similar Increased Risk Of Low-Stress Femur Fractures Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com ) The association between stress fractures of the femur, or ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 11 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.